Alembic

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: INE426A01027
  • NSEID: ALEMBICLTD
  • BSEID: 506235
INR
93.63
2.76 (3.04%)
BSENSE

Jun 18

BSE+NSE Vol: 9.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 919204,
    "name": "Alembic",
    "stock_name": "Alembic",
    "full_name": "Alembic Ltd",
    "name_url": "stocks-analysis/alembic",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "93.63",
    "chg": 2.76,
    "chgp": "3.04%",
    "dir": 1,
    "prev_price": "90.87",
    "mcapval": "2,429.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506235,
    "symbol": "ALEMBICLTD",
    "ind_name": "Realty",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE426A01027",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "9.07 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/alembic-919204-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-12 14:50:02",
        "description": "Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%  Business Standard..."
      },
      {
        "title": "Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-12 14:50:02",
        "description": "Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%  Business Standard..."
      },
      {
        "title": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-12 13:16:02",
        "description": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream  Business Standard..."
      },
      {
        "title": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-12 13:16:02",
        "description": "Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream  Business Standard..."
      },
      {
        "title": "Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules",
        "link": "https://news.google.com/rss/articles/CBMi_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?oc=5",
        "imagepath": "",
        "date": "2026-06-11 13:16:02",
        "description": "Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules  Business Standard..."
      },
      {
        "title": "Alembic Pharmaceuticals receives USFDA approval for Haloperidol Tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-05 11:31:20",
        "description": "Alembic Pharmaceuticals receives USFDA approval for Haloperidol Tablets  Business Standard..."
      },
      {
        "title": "Alembic gets USFDA nod for generic levothyroxine sodium tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-22 11:56:04",
        "description": "Alembic gets USFDA nod for generic levothyroxine sodium tablets  BusinessLine..."
      },
      {
        "title": "Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-22 11:17:36",
        "description": "Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets  Business Standard..."
      },
      {
        "title": "Alembic slides as Q4 PAT tanks 60% YoY to Rs 10 cr",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-20 15:04:30",
        "description": "Alembic slides as Q4 PAT tanks 60% YoY to Rs 10 cr  Business Standard..."
      }
    ],
    "total": 13,
    "sid": "919204",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/alembic-919204"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "11-Jun-2026",
      "details": "Please find enclose herewith paper cuttings of newspaper advertisement issued regarding another special window opened for transfer and dematerialization of physical securities.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Jun-2026",
      "details": "please find attached herewith a copy of the advance notice published in compliance with the procedure prescribed vide various circulars issued from time to time by MCA and SEBI inter alia informing the members about the 119th Annual General Meeting of the Company and sharing the procedure to register / update their details.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "05-Jun-2026",
      "details": "Please find enclosed herewith the specimen copy of the reminder letter sent to the shareholders holding shares in physical form for updating their KYC details.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Ltd has declared <strong>120%</strong> dividend, ex-date: 05 Aug 25",
          "dt": "2025-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Ltd has announced <strong>2:10</strong> stock split, ex-date: 26 Sep 06",
          "dt": "2006-09-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Sep 13",
          "dt": "2013-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%

2026-06-12 14:50:02

Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05% Business Standard...

Read More

Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%

2026-06-12 14:50:02

Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05% Business Standard...

Read More

Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream

2026-06-12 13:16:02

Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream Business Standard...

Read More

Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream

2026-06-12 13:16:02

Alembic Pharma gains after receiving USFDA nod for Tretinoin Cream Business Standard...

Read More

Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules

2026-06-11 13:16:02

Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules Business Standard...

Read More

Alembic Pharmaceuticals receives USFDA approval for Haloperidol Tablets

2026-06-05 11:31:20

Alembic Pharmaceuticals receives USFDA approval for Haloperidol Tablets Business Standard...

Read More

Alembic gets USFDA nod for generic levothyroxine sodium tablets

2026-05-22 11:56:04

Alembic gets USFDA nod for generic levothyroxine sodium tablets BusinessLine...

Read More

Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets

2026-05-22 11:17:36

Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets Business Standard...

Read More

Alembic slides as Q4 PAT tanks 60% YoY to Rs 10 cr

2026-05-20 15:04:30

Alembic slides as Q4 PAT tanks 60% YoY to Rs 10 cr Business Standard...

Read More
View All News stock news
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

11-Jun-2026 | Source : BSE

Please find enclose herewith paper cuttings of newspaper advertisement issued regarding another special window opened for transfer and dematerialization of physical securities.

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-Jun-2026 | Source : BSE

please find attached herewith a copy of the advance notice published in compliance with the procedure prescribed vide various circulars issued from time to time by MCA and SEBI inter alia informing the members about the 119th Annual General Meeting of the Company and sharing the procedure to register / update their details.

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

05-Jun-2026 | Source : BSE

Please find enclosed herewith the specimen copy of the reminder letter sent to the shareholders holding shares in physical form for updating their KYC details.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alembic Ltd has declared 120% dividend, ex-date: 05 Aug 25

stock-summary
SPLITS

Alembic Ltd has announced 2:10 stock split, ex-date: 26 Sep 06

stock-summary
BONUS

Alembic Ltd has announced 1:1 bonus issue, ex-date: 27 Sep 13

stock-summary
RIGHTS

No Rights history available

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."